Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2025-01-28 5:19 pm Sale | 2025-01-24 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 2,983,026 25.300% | -650,717![]() (-17.91%) | Filing History |
2024-02-09 10:05 am Sale | 2024-02-08 | 13G | XOMA Corporation XOMA | FMR LLC | 1,155,033 10.054% | -91,653![]() (-7.35%) | Filing History |
2024-01-16 5:22 pm Purchase | 2024-01-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,633,743 31.600% | 103,200![]() (+2.92%) | Filing History |
2023-02-09 12:46 pm Purchase | 2023-02-09 | 13G | XOMA Corporation XOMA | FMR LLC | 1,246,686 10.887% | 83,598![]() (+7.19%) | Filing History |
2022-08-10 08:10 am Purchase | 2022-08-09 | 13G | XOMA Corporation XOMA | FMR LLC | 1,163,088 10.183% | 275,566![]() (+31.05%) | Filing History |
2022-02-14 5:20 pm Sale | 2021-12-31 | 13G | XOMA Corporation XOMAO | Eagle Point Credit Management LLC | 0 0.000% | -149,248![]() (Position Closed) | Filing History |
2022-02-09 10:04 am Purchase | 2022-02-08 | 13G | XOMA Corporation XOMA | FMR LLC | 887,522 7.846% | 887,522![]() (New Position) | Filing History |
2021-04-19 4:53 pm Purchase | 2021-04-09 | 13G | XOMA Corporation XOMAO | Eagle Point Credit Management LLC | 149,248 6.300% | 149,248![]() (New Position) | Filing History |
2021-04-02 5:16 pm Sale | 2021-03-31 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 3,530,543 31.400% | -651,700![]() (-15.58%) | Filing History |
2020-12-15 5:21 pm Unchanged | 2020-12-11 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 37.900% | 0 (Unchanged) | Filing History |
2020-10-09 5:20 pm Unchanged | 2020-10-07 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 0 (Unchanged) | Filing History |
2020-09-23 5:28 pm Purchase | 2020-09-21 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,182,243 38.000% | 156,086![]() (+3.88%) | Filing History |
2020-08-19 4:31 pm Unchanged | 2020-08-06 | 13G | XOMA Corporation XOMA | NOVARTIS AG | 539,131 4.900% | 0 (Unchanged) | Filing History |
2020-04-17 4:54 pm Purchase | 2020-04-15 | 13D | XOMA Corporation XOMA | BIOTECHNOLOGY VALUE FUND L P | 4,026,157 36.600% | 12,703![]() (+0.32%) | Filing History |